{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T03:19:05Z","timestamp":1769743145501,"version":"3.49.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"41","license":[{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10,13]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>A predominant Th2 immune response is suggested in the pathogenesis of both minimal change disease (MCD) and membranous nephropathy (MN); however, consecutive development of the 2 diseases in a patient is extremely rare.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concern:<\/jats:title>\n            <jats:p>A Japanese man, who developed nephrotic syndrome in his 50s and was diagnosed with MCD by renal biopsy, experienced a relapse of proteinuria approximately 3 years later during long-term steroid treatment. Since the proteinuria was resistant to increase in steroid dosage, repeat renal biopsy was performed, which revealed a small amount of glomerular subepithelial immune deposits containing immunoglobulin (Ig)G (dominantly IgG4). Immunostaining for thrombospondin-type-1-domain-containing-7A (THSD7A) was positive on the glomerular capillary walls, whereas that for other causative antigens of MN, such as phospholipase A2 receptor or neural epidermal growth factor-like 1 protein, was negative. Detailed examination found no associated condition, including malignancies and allergic diseases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>The diagnosis of THSD7A-associated idiopathic MN was made.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions and outcomes:<\/jats:title>\n            <jats:p>He received further increased dose of steroids. Thereafter he maintained clinical improvement because his urinary protein level was decreased.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>The present case suggested that histological transition from MCD to MN is possible and repeat biopsy would be crucial for accurate diagnosis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000035470","type":"journal-article","created":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T21:10:39Z","timestamp":1697231439000},"page":"e35470","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Histological transition from minimal change disease to THSD7A-associated membranous nephropathy in a patient receiving long-term steroid treatment: A case report"],"prefix":"10.1097","volume":"102","author":[{"given":"Aki","family":"Kojima","sequence":"first","affiliation":[{"name":"Department of Nephrology and Blood Purification, Kidney Disease Center, Tokyo Medical University Hachioji Medical Center, Hachioji, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5852-9690","authenticated-orcid":false,"given":"Takahiro","family":"Uchida","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Blood Purification, Kidney Disease Center, Tokyo Medical University Hachioji Medical Center, Hachioji, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Sugisaki","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Blood Purification, Kidney Disease Center, Tokyo Medical University Hachioji Medical Center, Hachioji, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minami","family":"Koizumi","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Blood Purification, Kidney Disease Center, Tokyo Medical University Hachioji Medical Center, Hachioji, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Aoki","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Blood Purification, Kidney Disease Center, Tokyo Medical University Hachioji Medical Center, Hachioji, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuya","family":"Mukae","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Blood Purification, Kidney Disease Center, Tokyo Medical University Hachioji Medical Center, Hachioji, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muneharu","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Blood Purification, Kidney Disease Center, Tokyo Medical University Hachioji Medical Center, Hachioji, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Oda","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Blood Purification, Kidney Disease Center, Tokyo Medical University Hachioji Medical Center, Hachioji, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.","volume":"361","author":"Beck","year":"2009","journal-title":"N Engl J Med"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1056\/NEJMoa1409354","article-title":"Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.","volume":"371","author":"Tomas","year":"2014","journal-title":"N Engl J Med"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.2169\/internalmedicine.55.6885","article-title":"Complete remission of minimal change disease following an improvement of Lung mycobacterium avium infection.","volume":"55","author":"Yamashiro","year":"2016","journal-title":"Intern Med"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10157-018-1630-y","article-title":"Therapeutic efficacy of rituximab for the management of adult-onset steroid-dependent nephrotic syndrome: a retrospective study.","volume":"23","author":"Katsuno","year":"2019","journal-title":"Clin Exp Nephrol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/ndt\/gfaa133","article-title":"Comparison of treatment options in adults with frequently relapsing or steroid-dependent minimal change disease.","volume":"36","author":"Heybeli","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa1814427","article-title":"Rituximab or cyclosporine in the treatment of membranous nephropathy.","volume":"381","author":"Fervenza","year":"2019","journal-title":"N Engl J Med"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"e938402","DOI":"10.12659\/AJCR.938402","article-title":"A case of lupus nephritis preceded by minimal change disease and membranous glomerulonephritis.","volume":"24","author":"Zhang","year":"2023","journal-title":"Am J Case Rep"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s10157-021-02098-5","article-title":"A digest of the evidence-based clinical practice guideline for nephrotic syndrome 2020.","volume":"25","author":"Wada","year":"2021","journal-title":"Clin Exp Nephrol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"e0138841","DOI":"10.1371\/journal.pone.0138841","article-title":"Prevalence of enhanced granular expression of thrombospondin type-1 domain-containing 7A in the glomeruli of Japanese patients with idiopathic membranous nephropathy.","volume":"10","author":"Iwakura","year":"2015","journal-title":"PLoS One"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1038\/s41598-022-07037-2","article-title":"Prevalence of neural epidermal growth factor-like 1- and exostosin 1\/exostosin 2-associated membranous nephropathy: a single-center retrospective study in Japan.","volume":"12","author":"Iwakura","year":"2022","journal-title":"Sci Rep"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.2016010050","article-title":"An indirect immunofluorescence method facilitates detection of thrombospondin type 1 domain-containing 7A-specific antibodies in membranous nephropathy.","volume":"28","author":"Hoxha","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00428-019-02558-0","article-title":"Clinicopathological characteristics of thrombospondin type 1 domain-containing 7A-associated membranous nephropathy.","volume":"474","author":"Hara","year":"2019","journal-title":"Virchows Arch"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1080\/0886022X.2020.1819318","article-title":"Clinical characteristics of thrombospondin type-1 domain-containing 7A-associated membranous nephropathy.","volume":"42","author":"Suzuki","year":"2020","journal-title":"Ren Fail"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12882-021-02457-0","article-title":"Recurrent membranous nephropathy with a possible alteration in the etiology: a case report.","volume":"22","author":"Matsumoto","year":"2021","journal-title":"BMC Nephrol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/modpathol.2016.32","article-title":"THSD7A staining of membranous glomerulopathy in clinical practice reveals cases with dual autoantibody positivity.","volume":"29","author":"Larsen","year":"2016","journal-title":"Mod Pathol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000035470","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:12:51Z","timestamp":1746324771000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000035470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,13]]},"references-count":15,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000035470","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,13]]}}}